{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:13:09Z","timestamp":1791180789766,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5668,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.exphem.2006.07.008","type":"journal-article","created":{"date-parts":[[2006,12,6]],"date-time":"2006-12-06T07:11:17Z","timestamp":1165389077000},"page":"1663-1669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells"],"prefix":"10.1016","volume":"34","author":[{"given":"Clara","family":"Camp\u00e0s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana M.","family":"Cosialls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Iglesias-Serret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F.","family":"Santidri\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lloren\u00e7","family":"Coll-Mulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merc\u00e8","family":"de Frias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Domingo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Pons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2006.07.008_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Mechanisms of disease: chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2006.07.008_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood.V80.3.768.768","article-title":"bcl-2 gene expression in hematopoietic cell differentiation","volume":"80","author":"Mariano","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib3","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib4","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib5","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1084\/jem.171.2.559","article-title":"Preferential linkage of bcl-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia","volume":"171","author":"Adachi","year":"1990","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.exphem.2006.07.008_bib6","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2006.07.008_bib7","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2006.07.008_bib8","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood.V94.8.2836.420k35_2836_2843","article-title":"In vitro evaluation of fludarabine in combination with cyclophosphamide and\/or mitoxantrone in B-cell chronic lymphocytic leukemia","volume":"94","author":"Bellosillo","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1046\/j.1365-2141.1999.01642.x","article-title":"Bryostatin and CD40-ligand enhance apoptosis resistance and induce expression of cell survival genes in B-cell chronic lymphocytic leukaemia","volume":"106","author":"Kitada","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.07.008_bib10","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2141.2004.05225.x","article-title":"CD40 stimulation of B-cell chronic lymphocytic leukaemia cells enhances the anti-apoptotic profile, but also Bid expression and cells remain susceptible to autologous cytotoxic T-lymphocyte attack","volume":"127","author":"Kater","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.07.008_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.bbrc.2004.01.095","article-title":"Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells","volume":"315","author":"Sanz","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.exphem.2006.07.008_bib12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/ijc.20614","article-title":"High expression of Bfl-1 contributes to the apoptosis resistant phenotype in B-cell chronic lymphocytic leukemia","volume":"113","author":"Morales","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2006.07.008_bib13","first-page":"456","article-title":"Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome","volume":"10","author":"Robertson","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib14","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.4049\/jimmunol.156.7.2624","article-title":"Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX","volume":"156","author":"McConkey","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2006.07.008_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1034\/j.1600-0609.2000.90042.x","article-title":"Expression of bcl-2 and bax in cells isolated from B-chronic lymphocytic leukemia patients at different stages of the disease","volume":"64","author":"Aviram","year":"2000","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2006.07.008_bib16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/sj.leu.2402540","article-title":"Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL)","volume":"16","author":"Faderl","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib17","doi-asserted-by":"crossref","first-page":"E43","DOI":"10.1038\/35055145","article-title":"Death by design: the big debut of small molecules","volume":"3","author":"Zheng","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2006.07.008_bib18","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/sj.leu.2403029","article-title":"Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family","volume":"17","author":"Shangary","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib19","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2004-07-2761","article-title":"Apoptosis-based therapies for hematological malignancies","volume":"106","author":"Reed","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nbt0405-409","article-title":"New apoptosis drugs face critical test","volume":"23","author":"Garber","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.exphem.2006.07.008_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2004.07.011","article-title":"Antiapoptotic Bcl-2 is required for maintenance of a model of leukemia","volume":"6","author":"Letai","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.exphem.2006.07.008_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1046\/j.1365-2141.1999.01726.x","article-title":"Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia","volume":"107","author":"Pepper","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2006.07.008_bib23","doi-asserted-by":"crossref","first-page":"7697","DOI":"10.1200\/JCO.2005.02.4364","article-title":"Phase I to II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in patients with advanced chronic lymphocytic leukemia","volume":"23","author":"O'Brien","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2006.07.008_bib24","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells","volume":"97","author":"Wang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2006.07.008_bib25","first-page":"961","article-title":"The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195","volume":"1","author":"Chen","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2006.07.008_bib26","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1038\/sj.leu.2403102","article-title":"HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia\/lymphoma cells, and enhances cytarabine-induced cell death","volume":"17","author":"Lickliter","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib27","doi-asserted-by":"crossref","first-page":"19133","DOI":"10.1074\/jbc.M400295200","article-title":"Critical upstream signals of cytochrome C release induced by a novel Bcl-2 inhibitor","volume":"279","author":"An","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2006.07.008_bib28","doi-asserted-by":"crossref","first-page":"8284","DOI":"10.1158\/1078-0432.CCR-04-1289","article-title":"Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells","volume":"10","author":"Sinicrope","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.exphem.2006.07.008_bib29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.canlet.2004.09.012","article-title":"Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent","volume":"221","author":"Reiners","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.exphem.2006.07.008_bib30","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.leukres.2005.08.022","article-title":"HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells","volume":"30","author":"Skommer","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.exphem.2006.07.008_bib31","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/sj.leu.2403109","article-title":"The proteasome inhibitor bortezomib promotes mitochondrial injury and apoptosis induced by the small molecule Bcl-2 inhibitor HA14-1 in multiple myeloma cells","volume":"17","author":"Pei","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib32","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1158\/1535-7163.1513.3.12","article-title":"The small-molecule Bcl-2 inhibitor HA14-1 interacts synergistically with flavopiridol to induce mitochondrial injury and apoptosis in human myeloma cells through a free radical-dependent and Jun NH2-terminal kinase-dependent mechanism","volume":"3","author":"Pei","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.exphem.2006.07.008_bib33","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-03-3648","article-title":"Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondrial respiration in human leukemic CEM cells","volume":"64","author":"Hao","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2006.07.008_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/35055095","article-title":"Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3","volume":"3","author":"Tzung","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.exphem.2006.07.008_bib35","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1021\/bi002368e","article-title":"Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A","volume":"40","author":"Kim","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.exphem.2006.07.008_bib36","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1182\/blood.V99.9.3461","article-title":"Synergistic induction of apoptosis by simultaneous disruption of the Bcl-2 and MEK\/MAPK pathways in acute myelogenous leukemia","volume":"99","author":"Milella","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib37","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1182\/blood-2002-07-2339","article-title":"Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes","volume":"101","author":"Camp\u00e0s","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib38","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/sj.leu.2402860","article-title":"Prodigiosin induces apoptosis of B and T cells from B-cell chronic lymphocytic leukemia","volume":"17","author":"Camp\u00e0s","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2006.07.008_bib39","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1182\/blood.V84.10.3440.3440","article-title":"Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogs","volume":"84","author":"Silber","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib40","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1182\/blood-2005-08-3273","article-title":"MDM2 antagonists activate p53 and synergize with genotoxic drugs in B-cell chronic lymphocytic leukemia cells","volume":"107","author":"Coll-Mulet","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cyto.10156","article-title":"Antimycin A-induced apoptosis of HS-60 cells","volume":"49","author":"King","year":"2002","journal-title":"Cytometry"},{"key":"10.1016\/j.exphem.2006.07.008_bib42","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood.V84.9.3148.3148","article-title":"p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies","volume":"84","author":"Wattel","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib43","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1182\/blood.V91.11.4342","article-title":"p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosis","volume":"91","author":"Cordone","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2006.07.008_bib44","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.exphem.2006.07.008_bib45","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"issue":"11S","key":"10.1016\/j.exphem.2006.07.008_bib46","first-page":"135A","article-title":"A phase I trial of the small molecule Pan-Bcl-2 family inhibitor GX15-070 administered intravenously (IV) every 3 weeks to patients with previously treated chronic lymphocytic leukemia (CLL)","volume":"106","author":"O'Brien","year":"2005","journal-title":"Blood"},{"issue":"16S","key":"10.1016\/j.exphem.2006.07.008_bib47","first-page":"233S","article-title":"GX15-070MS, a synthetic small molecule induces apoptosis in vitro and in vivo in chronic lymphocytic leukaemia","volume":"23","author":"Castro","year":"2005","journal-title":"J Clin Oncol"},{"issue":"16S","key":"10.1016\/j.exphem.2006.07.008_bib48","first-page":"236S","article-title":"Initial results from ongoing phase I trials of a novel pan bcl-2 family small molecule inhibitor","volume":"23","author":"McGreivy","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18S","key":"10.1016\/j.exphem.2006.07.008_bib49","article-title":"A phase I study of the pan-Bcl2 family inhibitor GX15-070, administered as a 3-hour weekly infusion in patients with refractory solid tumors or lymphomas","volume":"24","author":"Firozvi","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.exphem.2006.07.008_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06004486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X06004486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:22:09Z","timestamp":1759566129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X06004486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0301472X06004486"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2006.07.008","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2006.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}